Compare RANI & ACNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RANI | ACNT |
|---|---|---|
| Founded | 2012 | 1945 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Steel/Iron Ore |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 134.6M | 118.8M |
| IPO Year | 2021 | N/A |
| Metric | RANI | ACNT |
|---|---|---|
| Price | $1.48 | $15.50 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $8.67 | N/A |
| AVG Volume (30 Days) | ★ 2.8M | 77.0K |
| Earning Date | 11-06-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.09 |
| Revenue | $1,200,000.00 | ★ $171,413,000.00 |
| Revenue This Year | $414.59 | $22.72 |
| Revenue Next Year | $30.15 | N/A |
| P/E Ratio | ★ N/A | $162.95 |
| Revenue Growth | N/A | ★ 65.05 |
| 52 Week Low | $0.39 | $10.76 |
| 52 Week High | $3.87 | $15.70 |
| Indicator | RANI | ACNT |
|---|---|---|
| Relative Strength Index (RSI) | 44.28 | 71.49 |
| Support Level | $1.52 | $14.74 |
| Resistance Level | $1.67 | $15.69 |
| Average True Range (ATR) | 0.14 | 0.59 |
| MACD | -0.03 | 0.03 |
| Stochastic Oscillator | 28.57 | 91.67 |
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.
Ascent Industries Co is a specialty chemicals platform focused on the development, production, and distribution of tailored, performance-driven chemical solutions. It has one reportable segment: Specialty Chemicals. The Specialty Chemicals segment includes the operating results of the Company's plants involved in the production of specialty chemicals and produces critical ingredients and process aids for the oil & gas, household, industrial and institutional (HII), personal care, coatings, adhesives, sealants and elastomers (CASE), pulp and paper, textile, automotive, agricultural, water treatment, construction and other industries.